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Abstract
HIV-1 Gag Trafficking and Assembly: Mathematical Models and
Numerical Simulations
AIDS (acquired immune deficiency syndrome) is an infectious disease that takes away
many people’s lives each year. Group-specific antigen (Gag) polyprotein precursor is the
major structural component of HIV, the causing agent of AIDS. Gag is essential and sufficient
for the formation of new HIV virus-like particles. The late stages of the HIV-1 life cycle
include the transport of Gag proteins towards the cell membrane, the oligomerization of
Gag near the cell membrane during the budding process, and core assembly during virion
maturation. The mechanisms for Gag protein trafficking and assembly are not yet fully
understood. In order to gain further insight into the mechanisms of HIV-1 replication, we
develop and analyze mathematical models and numerical algorithms for intracellular Gag
protein trafficking, Gag trimerization near the cell membrane, and HIV-1 core assembly.
Our preliminary results indicate that active transport plays an important role for Gag
trafficking in the cytoplasm. This process can be mathematically modeled by convection-
diffusion equations, which can be solved efficiently using characteristic finite element meth-
ods. We employ differential dynamical systems to model Gag trimerization and HIV-1 core
assembly.
For the Gag trimerization model, we estimate relationships between the association and
dissociation parameters as well as the Gag arrival and multimerization parameters. We also
find expressions for the equilibrium concentrations of the monomer and trimer species, and
show that the equilibrium is asymptotically stable.
ii
For HIV-1 core assembly, we first consider a model developed by Zlonick and others, which
regards assembly as a polymerization reaction. We utilize theoretical and numerical tools
to confirm the stability of the equilibrium of CA intermediates. In addition, we propose
a cascaded dynamical system model for HIV-1 core assembly. The model consists of two
subsystems: one subsystem for nucleation and one for elongation. We perform simulations
on the nucleation model, which suggests the existence of an equilibrium of the CA species.
Keywords: capsid, convection, diffusion, equilibrium, finite elements, Gag, HIV, micro-
tubules, transport, trimerization, viral assembly
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CHAPTER 1
Biological Problems - HIV and Gag
1.1. AIDS and HIV
Human immunodeficiency virus type 1 (HIV-1), the causative agent of acquired immun-
odeficiency syndrome (AIDS), was discovered in early 1980’s [1]. More than three million
people die each year from AIDS, and roughly 40 million people are infected with HIV [1] .
It is believed that HIV descended from simian immunodeficiency virus (SIV). From the
evolutionary point of view, AIDS is a new disease and humans have not adapted to it yet.
HIV attacks T lymphocytes and macrophages. In particular, HIV infects and kills CD4+
T helper cells [1, 2] , which coordinate the immune response against invading pathogens.
Untreated infected individuals usually develop AIDS about 8-10 years after infection [1].
Most people with AIDS have very weak immune systems, and they eventually die due to the
body’s inability to fight off infections.
HIV is a retrovirus, which means that its genome is stored in RNA form instead of DNA.
The replication process of a retrovirus is error-prone, and therefore retroviruses have a high
mutation rate [1, 2]. On average, there is a one-point mutation in each replication cycle of
HIV. This is due to the fact that the enzyme reverse transcriptase, which transcribes the
virus’s RNA genome into DNA form, “cannot correct nucleotide misincorporation errors” [2]
(p. 1450). Only about one-third of HIV’s coding sequences in its genome remains invariant.
This presents a big dilemma. Not only is it very difficult for the immune system to fight off
HIV, but also it is extremely challenging to develop effective vaccines against this pathogen
[2] .
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Many different treatments for HIV have been developed, and there has been much
progress in this regard. On the other hand, there is still much to be learned about the
way the pathogen that causes AIDS replicates in the infected cell. We aim to better under-
stand the HIV’s life cycle in order to aid in determining more efficient ways to treat this
disease.
There are two main different types of HIV: HIV-1 and HIV-2, which seem to have evolved
separately from different strains of SIV. HIV-2 is less virulent and is not as widely spread
[1, 2]. In this work, unless otherwise specified, HIV refers to HIV-1.
1.2. HIV and Gag
In order to better comprehend HIV’s replication cycle, we need to understand the virus’s
composition and structure. Several main proteins, such as Env, Pol, Gag, and others com-
prise HIV[2, 3, 4]. Our focus in this study is on the main structural component of HIV
particles, the Gag protein [3, 5, 6].
Gag. Gag (group specific antigen) is essential in the formation of new HIV virions,
each of which is enveloped, of spherical shape [2, 3], and consists of approximately 5, 000 Gag
molecules. In vivo, Gag is sufficient for the formation of new HIV virus-like particles (VLP’s).
Uncleaved Gag surrounds the HIV RNA genome and spreads radially in the immature virion
[3, 5, 8, 9, 10].
The major domains of Gag are: matrix (MA), capsid (CA), nucleo-capsid (NC), and p6
(see Figure 1.1). Gag binds to the plasma membrane via its MA domain. The CA domain
forms the outer shell of the mature HIV virion’s core during the maturation stage. Gag
multimerizes via its CA and NC domains. The NC domain binds to viral RNA. Gag utilizes
its p6 domain and the host cell’s plasma membrane during budding [3, 10, 12, 13].
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Retroviral Lifecycle. HIV utilizes CD4 receptors to enter CD4 T cells and macro-
phages [2, 7]. The virus invades the host cell by fusing with the plasma membrane, and
releases its genomic RNA and other proteins into the cytoplasm [2] . The enzyme reverse
transcriptase converts the RNA into DNA, which is then integrated into the host cell’s DNA
by the enzyme integrase [2] . The host cell transcribes the viral DNA into viral mRNA,
which then travels to the cytoplasm. From mRNA, new Gag proteins are synthesized in the
cytoplasm on free polysomes (clusters of ribosomes) [14, 15]. Nermut et al. [15] found in
their study that the Gag precursor pr55Gag first appeared in the cytoplasm of an infected
cell at 28-30 hours post infection. (h.p.i.). The newly synthesized Gag proteins, associated
to viral RNA, travel to the plasma membrane via diffusion and active transport [16]. Gag
protein transport to the plasma membrane after synthesis takes about 5-10 minutes [7].
Transport mediated by motor proteins along microtubules has been proposed as a mechanism
Figure 1.1. HIV and Gag. The Gag domains MA, CA, NC, and p6 are the
main structural components of the HIV particle. The MA domain binds to the
interior side of the viral membrane. The CA domain forms the viral core shell.
The NC domain is attached to the RNA inside the core. p6 is involved in the
virion’s budding from the host cell. Source: [7] (with slight modification).
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for intracellular active transport of Gag proteins [14, 17]. Multimerization of Gag molecules
takes place at the plasma membrane, where new immature virions assemble right before or
during budding. This process starts at around 6-8 hours after the Gag proteins are first
synthesized in the cytoplasm [9, 15]. However, the speed at which the Gag proteins are
produced and transported seems to vary depending on the type of cell. Nermut et al. [15]
found in their experiments that the majority of Sf9 cells were in the budding stage at 40 to
44 h.p.i., while in T4 lymphocytes, budding took 2 or 3 days to begin. Assembly of the new
virions at the plasma membrane takes about 5-6 minutes [9]. The immature virions leave
the infected cell and begin the process of maturation. During this stage, each newly formed
Figure 1.2. Cell Structure. Human cells have various shapes and sizes, but
most of them have similar components, some of which are: the nucleus, where
the host’s genome is packaged as DNA strands; a cytoplasm, which contains
the cell’s organelles; a nuclear envelope, that separates the nucleus from the
cytoplasm; a plasma (cell) membrane, which gives the cell its shape and through
which materials are exported and imported; microtubules, which serve as the
cell’s scaffold and are involved in cell movement and trafficking of particles in
the cytoplasm. Source: [2].
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immature virion develops a core, which contains RNA and other proteins [3, 10] (see Figures
1.2, 1.3, and 1.4).
1.3. HIV Maturation
New HIV virions that form near the plasma membrane of a host cell escape the cell
during the process of budding. These immature virions are not yet infectious. They need to
undergo a maturation process in order to be able to invade and infect other cells. During
maturation, Gag proteins are cleaved by the enzyme protease. The MA domain remains
Figure 1.3. Retrovial Lifecycle. HIV fuses with the host cell’s plasma mem-
brane and releases its RNA and enzymes in the cytoplasm. HIV’s RNA is
translated to DNA by the enzyme reverse transcriptase. The viral DNA is
integrated into the host cell’s DNA by the enzyme integrase. The host cell
translates the viral DNA into viral mRNA. The mRNA produces Gag proteins
in the cytoplasm, which travel to the cell membrane, the site of assembly of new
immature virions. The virions leave the cell during the budding process, and
develop a core and become infective during maturation. Source: [11] (with
slight modification).
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attached to the virion’s membrane, while about 1, 500 of the CA proteins form the outer
shell or capsid of the mature virion’s core. NC is bound to two RNA strands, which are
packaged inside the core, along with other viral proteins [3, 8, 10, 19] (see Figure 1.5).
HIV Core Assembly. The outer shell of the mature HIV core or capsid (see Figure
1.6) is composed of about 1, 500 Gag capsid domain (CA) proteins [8, 20], bound together
by weak inter-subunit interactions. The HIV core is a globally stable lattice. The stability
of protein-protein interactions is required for assembly [3]. HIV core assembly consists of
two main stages: nucleation and elongation.
Nucleation and Elongation. Nucleation is the formation of a nucleus (polygon)
and is usually characterized by a lag phase [2, 21, 22]. For the HIV core, we assume the
nucleus size to be nnuc = 6, since CA hexamers are the main subunit in the process of HIV
core assembly [18]. Elongation is the addition of subunits to the already formed nucleus,
Figure 1.4. HIV Egress. New mRNA forms in the host cell’s nucleus and
travels to the cytoplasm, where it synthesizes new Gag proteins. Studies suggest
that these proteins can move through the cytoplasm via diffusion and active
transport along microtubules, while attached to the motor protein KIF4 and
carrying RNA, towards the cell membrane. Gag proteins accumulate near the
cell membrane and form new HIV virions, which then bud off the cell. Source:
[13].
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and it is usually characterized by a rapid growth phase and an equilibrium phase [2] . The
process of elongation is typically fast compared to nucleation, in terms of the rate at which
subunits are added to the growing structure [22].
1.4. Roles of Mathematical Modeling for HIV and Gag
Quantitative description of the aforementioned biological problems, in particular mathe-
matical models, will help us understand the mechanisms of the HIV life cycle. Well-developed
mathematical models shall provide quantitative characterization of detailed aspects of HIV
reproduction. Here, we highlight the efforts and contributions of this thesis.
Models for Gag Trafficking Inside Cytoplasm. We first consider a mathematical
model for Gag trafficking in the cytoplasm. We assume the cytoplasm is an annulus, where
Figure 1.5. Immature and Mature HIV Virions. About 5, 000 Gag proteins
are spread radially and uniformly inside the immature HIV virion (left). In the
mature HIV virion (right), Gag’s MA domain (yellow) is attached to the inner
layer of the virion’s membrane, while about 1, 500 of the available 5, 000 CA
proteins form the capsid (outer shell) of the virion’s core. The core packages
two strands of viral RNA and other proteins. Source: [10].
7
Gag proteins are produced uniformly at a constant rate. The model consists of a partial
differential equation with a diffusion term and a convection term, accounting for the diffusion
and active transport of Gag proteins. Active transport may take place, for instance, along
microtubules via motor proteins. We also assume radial symmetry in the transport of Gag
proteins. Our Robin boundary conditions reflect the assumptions that Gag proteins do not
penetrate back into the nucleus and that no Gag proteins escape the cell through the plasma
membrane until a Gag concentration threshold has been reached. The initial condition
reflects the assumption that there are no Gag proteins in the cytoplasm at the start of the
process. We perform numerical simulations for various combinations of parameter values.
Our simulations agree principally with experimental results. We also comment on further
work on the trafficking model by considering stochasticity of the parameters, in particular
the active transport parameter.
Figure 1.6. HIV Core. The mature HIV core shell is composed of about
1, 500 CA proteins, mostly in the form of hexamers. The core also contains 12
CA pentamers, 5 of them in the narrow end, and the other 7 in the wide end
of the capsid. This arrangement gives the HIV core its conical shape. Source:
[18].
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Models for Gag Trimerization at Plasma Membrane. We also develop and
analyze a mathematical model for Gag trimerization at the plasma membrane. HIV Gag
accumulates near the plasma membrane at certain “Gag hotspots”, where HIV virion assem-
bly takes place. We assume that Gag proteins arrive at the site of assembly as monomers,
at a constant rate. Three monomers can come together to form a trimer, and one trimer
can decompose into three monomers. Trimers can come together to form higher order mul-
timers, which bind to each other and to the plasma membrane as a new immature HIV
virion assembles. Our trimerization model consists of a nonlinear dynamical system of two
ordinary differential equations. The equations represent the rates of change in the concen-
trations of Gag monomers and trimers at a Gag hotspot. We show analytically and verify
numerically the existence and stability of a unique equilibrium of the monomer and trimer
species, regardless of parameter values, as long as all parameters are positive.
In addition, we estimate the ratios of Gag association and dissociation parameters and
the ratio of Gag monomer arrival and Gag multimerization parameters based on values from
literature and from experimental data. We also derive a condition on the model parameters
that shift the Gag monomer-trimer equilibrium towards the trimer state. We verify the
condition numerically. We then calculate a lower bound for the equilibrium association
constant Ka for Gag monomers and trimers. Finally, we comment on further work on Gag
trimerization modeling in terms of possible improvements to the model.
Models for HIV Core Assembly. We paid out attention to HIV core assembly also.
We utilize nonlinear systems of ordinary differential equations for representing the rates of
change of the concentrations of CA intermediates in the assembly of a mature HIV virion
core.
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The first model, based on a model proposed by Zlotnick and others for virus capsid
assembly [23], considers hundreds of species of CA intermediates, from CA monomers up to
a full capsid (mature HIV core shell). We ran numerical simulations for a total of N = 1, 300
and N = 5, 000 CA intermediates, assuming higher association rates and lower dissociation
rates for larger CA multimer species. Our simulations provide verification of the existence of
a stable equilibrium. We showed analytically the existence of a unique equilibrium, and also
showed that the equilibrium is stable regardless of parameter values, as long as all parameters
are positive, for the case when there are only three CA intermediates.
Next, we consider a cascaded dynamical system for HIV core assembly. There are two
subsystems, the first one corresponding to the nucleation of a CA hexamer, and the second
one corresponding to the elongation of the mature virion capsid. The first system consists of
six nonlinear ordinary differential equations, representing the rates of change of the concen-
trations of CA intermediates 1 through 6, that is, monomers through hexamers. We consider
various paths of assembly of these intermediates. We verify numerically the existence of a
stable equilibrium for this six-species model. The elongation system of differential equations
is similar to the model proposed by Zlotnick’s group for capsid assembly, adapted to HIV
core assembly. In particular, there are about N = 250 differential equations (instead of
N = 1, 500 equations), corresponding to the concentrations of CA 6-mers, 12-mers, ..., and
capsid. That is, the basic subunit is now a CA hexamer instead of a monomer. We also
comment on further work on HIV core assembly.
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CHAPTER 2
Gag Trafficking Inside the Cytoplasm
2.1. Biological Background and Existing Work
Figure 2.1. Microtubule Structure. Microtubules are hollow cylinders, about
25nm in diameter, and are part of the cell’s cytoskeleton. Source: [24].
Figure 2.2. Motor Proteins. Dyneins move in retrograde fashion, towards the
minus-end of microtubules. Most kinesins exhibit anterograde motion, towards
the plus-end of microtubules. Source: [25].
Proteins and other particles may be transported inside the cell along microtubules (see
Figure 2.1). These structures made of tubulin are hollow tubes, about 25 nm in diameter and
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between 50 and 100 µm long [28]. There are typically about 150 microtubules in a cell [28].
Microtubules radiate from the microtubule organization center (MOTC) near the nucleus
towards the plasma membrane. They serve as tracks for motor proteins, which attach to
cellular cargoes and move along microtubules either towards the minus-end (dyneins) or the
plus-end (kinesins) of the microtubules (see Figures 2.2 and 2.3). Studies have found that
motor proteins for movement towards the plus-end and the minus-end of microtubules are
present simultaneously on cellular cargo [29].
The mechanisms of intracellular HIV Gag trafficking and virus assembly are poorly un-
derstood [7, 30]. Gag proteins are present in the cytosol mostly as monomers and low order
oligomers [6, 9, 10]. In experiments, it has been found that kinesin KIF4 associates with
retroviral Gag protein [31]. Moreover, KIF4 disruption slows down HIV Gag trafficking in
the cytoplasm and inhibits production of new virus particles [14]. There is also evidence
that disrupting microtubules with the drug nocodazole reduces HIV infection twofold [32].
In addition, cells contain a stable pool of nocodazole-resistant microtubules [14]. Martinez
Figure 2.3. Structure of Kinesin. Kinesin uses its two heads to walk along
microtubules in 8nm steps [26]. Kinesin’s tail is attached to cargo, which is
transported along the microtubule towards the plasma membrane. Source:
[27].
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and co-workers propose that HIV Gag trafficking might depend mostly on this stable pool
of microtubules, whose selection could be enhanced by association with KIF4 [14].
In the following sections, we present and analyze a mathematical model for intracellular
HIV Gag trafficking. Our model will consider Gag transport towards the plasma membrane.
We aim to better understand the dynamics of Gag protein transport. Specifically, we look at
the relationships between diffusion and active transport parameters and the assembly time
of new virus particles at the plasma membrane. The numerical methods used in simulations
are based on finite elements and characteristic tracking [16, 33, 34, 35, 36, 37, 38, 39].
2.2. A Quasi-2D Model for Gag Trafficking
Figure 2.4. Annular Model of the Cytoplasm. Our Gag trafficking model
assumes that the host cell’s cytoplasm has annular form and that Gag proteins
are transported via diffusion and active transport. The transport is assumed
to be symmetric with respect to the angle. Thus, the model considers motion
in the radial direction. Here, ra and rb represent the radius of the nucleus and
of the cell, respectively. Source: [16].
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2.2.1. Assumptions. We list here the main assumptions of our mathematical model for
Gag trafficking (see Figure 2.4):
• The cell’s cytoplasm is an annulus.
• All Gag species are treated as quasi-monomers.
• There is no association or dissociation among Gag species during intracellular trans-
port.
• Gag transport happens via diffusion and active transport along microtubules.
• Gag monomers are produced uniformly and constantly from mRNA in the cyto-
plasm.
• Gag particles do not penetrate back into the nucleus.
• Gag particles cannot escape through the plasma membrane before virions form.
• Initial monomeric Gag concentration in the cytoplasm is zero.
2.2.2. Gag Active Transport. Variables and Parameters. We define here the
main quantities involved in our model for Gag trafficking:
• s = speed of Gag on microtubules in the radial direction (µm/sec)
• v = (s cos θ, s sin θ) = velocity vector (µm/sec, µm/sec)
• D = diffusion coefficient (µm2/sec)
• g = rate of production of new Gag protein (µM/sec)
• P (r, θ, t) = P (r, t) = concentration of Gag at distance r from the cell center at time
t (µM)
• Tv = time when new virion first appears on cell membrane, that is, the Gag con-
centration near plasma membrane reaches a certain threshold value (sec).
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Mass Conservation. The mass conservation law asserts that temporal change in mass
concentration is balanced by spatial change (flux) plus production (source, sink). Mathe-
matically, this can be expressed as the following partial differential equation:
∂P
∂t
= ∇ · (D∇P − vP ) + g.
In polar coordinates, the total flux can be expressed as follows:

















− srP ) + g, r ∈ (ra, rb), t ∈ (0, Tv)
(Dr ∂P
∂r
− srP )|ra = (Dr ∂P∂r − srP )|rb = 0, t ∈ (0, Tv)
P (r, 0) = 0, r ∈ (ra, rb).
Robin boundary conditions with zero total flux at the two ends are proposed to reflect
the assumption of no penetration back into the nucleus and no escape through the plasma
membrane before new virions form. Numerical algorithms for the above initial boundary
value problem can be developed based on characteristic finite element methods.
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2.2.3. Variational Formulation for the Quasi-2D Model. We rewrite equation











= gr, r ∈ [ra, rb], t ∈ [0, Tv].
The development of the numerical method is divided into two stages. A weak formulation
based on a temporal discretization is first established. Then we apply a spatial finite element
discretization to obtain a discrete algebraic system.
Let 0 < t1 < . . . < tn−1 < tn < · · · < tN = Tv be a temporal partition of [0, Tv] that
is not necessarily uniform and ∆tn = tn − tn−1(n = 1, . . . , N). We consider test functions
defined on the space-time slab Σ = [ra, rb]× [tn−1, tn]. Multiplying both sides of equation (2)























For the first term on the left-hand side of equation (3), Fubini’s theorem and integration






































For the second term on the left-hand side of equation (3), we apply integration by parts in



















































































which is equivalent to
∫ rb
ra












































Clearly, this implies that any test function is a constant along each characteristic, i.e.,
(8) ψ(r, t) = ψ(r∗, t∗).







































Figure 2.5. The space-time slab Σ = [ra, rb] × [tn−1, tn] is divided into three
regions Σ1,Σ2,Σ3 by two special characteristics: the one connecting (ra, tn−1)
and (r+a , tn), and the one connecting (r
−
b , tn−1) and (rb, tn).
As shown in Figure 2.5, the space-time slab [ra, rb] × [tn−1, tn] is divided into three re-
gions by two special characteristics: the one connecting (ra, tn−1) and (r
+
a , tn), and the one
connecting (r−b , tn−1) and (rb, tn), where
(10) r+a = ra + s∆tn, r
−
b = rb − s∆tn.
2.2.4. Finite Element Discretization. Next we consider spatial discretization and
approximate the diffusion term in the weak form (9). For time step tn, let ra = r0 < r1 <
· · · < rj−1 < rj < . . . < rM = rb with hj = rj − rj−1(j = 1, . . . ,M) be a nonuniform spatial
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mesh. We shall adopt local mesh refinements and Lagrangian P1 spatial elements at each
time step. Let φj(r)(j = 0, . . . ,M) be the nodal basis (hat) functions for a typical time
step. Note that φ0 has only the right half of the hat, whereas φM has only the left half. It
should be pointed out that the spatial partition, the number of spatial elements M , and the
nodal basis functions are generally different for different time steps. We shall assume this














Figure 2.7. An illustration of the last test function ψM(r, t)
Our finite element approximation is different from the traditional ones. The trial basis
functions are spatial hat functions as described above, whereas the test basis functions are
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space-time functions that satisfy the adjoint equation (7). To be precise, let us look at a
typical time stepping from tn−1 to tn. The unknown approximate solution P
(n)(r) at time
step tn is a linear combination of the spatial hat functions φj(j = 0, . . . ,M) with unknown
coefficients {P (n)j }Mj=0. There areM+1 space-time test functions ψ(r, t) that are defined in the
space-time slab Σ = [ra, rb]×[tn−1, tn] and satisfy the adjoint equation. Any test function is a
constant along each characteristic within its support. For 0 ≤ i ≤ (M −1), ψi(r, tn) = φi(r).
So the support of ψ0(r, t) is a region in Σ that is bounded by the boundary of Σ and the
backtracking characteristic starting from (r1, tn). The support of ψi(r, t)(i = 1, . . . ,M−1) is
a region in Σ that is bounded by the two backtracking characteristics starting from (ri−1, tn)
and (ri+1, tn), respectively. An illustration of these test functions is shown in Figure 2.6.
However, the last test function ψM(r, t) is special. Its support consists of two parts. The
first part is the region in Σ that is bounded by the two backtracking characteristics starting
from (rM−1, tn) and (rM , tn), respectively. Similarly, ψM(r, tn) = φM(r). The second part of
the support is Σ3 and ψM(r, t) ≡ 1 on Σ3.
For the diffusion term in the weak form (9), our treatment is similar to that in [38].
Because the diffusion is small, the test functions are constants along characteristics, and the




















where ∆t(r, tn) = tn−t∗ and (r∗, t∗) is the foot of the characteristic starting from (r, tn). This
approximation holds for all test basis functions. Clearly, if ra ≤ r < r+a , then t∗ ∈ (tn−1, tn]
and hence ∆t(r, tn) < ∆tn. But if r
+
a ≤ r ≤ rb, then t∗ = tn−1 and hence ∆t(r, tn) = ∆tn.
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Substituting (9) into (11), we obtain a finite element scheme for equation (1). At each
time step tn(1 ≤ n ≤ N), seek




























To start the time-stepping procedure, P (0)(r) can be taken as the piecewise linear nodal
interpolation of the initial condition p0(r).
Next we discuss how to evaluate the mass matrix, the stiffness matrix, and the right-hand
side in the discrete linear system. The mass matrix


















(r2i − r2i−1), Ai,i+1 =
1
12




(ri − ri−1)(3ri + ri−1) +
1
12




(r2M − r2M−1), AM,M =
1
12
(rM − rM−1)(3rM + rM−1),
where 1 ≤ i ≤ (M − 1).
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The stiffness matrix











is also a symmetric tridiagonal matrix, but its evaluation is a little bit more involved, since
∆tn(r, tn) relies on characteristic tracking. Suppose r
+
a ∈ (rI−1, rI ] for some I ≥ 1 (but
I  M). It is known that ∆t(r, tn) = ∆tn for r ≥ r+a . So explicit expressions are available























, for (I + 1) ≤ i ≤ (M − 1),






For the evaluation of B0,0, B0,1 = B1,0, B1,1, B1,2 until BI,I−1, BI,I , Gaussian quadratures
could be employed.
The evaluation of the right-hand side of (13) depends on the test functions and char-
acteristic tracking. For the first few test basis functions, their supports do not intersect
with [ra, rb] × {tn−1}, so ψ(r, t+n−1) = 0 and hence the corresponding entries are zero. For a
test function whose support intersects with [ra, rb]× {tn−1}, we apply change of variable to
evaluate the integral. For simplicity of presentation, we assume that both suppψ(r, tn) and
suppψ(r, t+n−1) are in [ra, rb]. We replace the dummy integral variable r by r
∗ and rewrite
















The above right-hand side could be evaluated by a Gaussian quadrature on suppψ(r, tn),
therein P (n−1)(r∗) is evaluated through linear interpolation after r∗ is located.
Once again the evaluation of the right-hand side involving the last test basis function
ψM(r, t) is divided into two parts due to the two-part structure of its support. The calculation




because ψM(r, t) ≡ 1 on Σ3. An explicit formula is available for the above integral, since
P (n−1)(r) is piecewise linear on [r−b , rb].
Finally, we obtain a tridiagonal linear system with unknowns {P (n)j }Mj=0 and the coeffi-
cient matrix (A + B). The linear system can be solved directly with spatial and temporal
complexities both O(M).
Mass Conservation. By construction,
M∑
i=0
ψi(r, t) ≡ 1 on the space-time slab [ra, rb]×









Therefore, our numerical scheme is mass-conservative by design. Since piecewise linear ap-
proximations to the unknown concentration are adopted in our numerical scheme, an explicit



























However, the evaluations of the coefficient matrix entries and the right-hand side of the linear
system involve quadrature errors and round-off errors, the actual total mass might fluctuate
slightly from time to time. The above formula can be used for checking mass conservation
in numerical experiments.
2.3. Simulation Results
Figure 2.8. Simulated Radial Distribution of Gag Concentration. Speed s =
2, Diffusion D = 0.04, ra = 5, rb = 10 [40, 41].
We estimate the threshold concentration Pv, that is, the Gag concentration at the plasma
membrane needed for a new HIV virion to form, as follows. We assume it takes 4,500 Gag
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Table 2.1. Simulated Time of Virion Assembly. Source: [16]
Speed s (µm/sec) Time Tv
2.00 09h 46m 41s
1.00 10h 14m 35s
0.40 10h 32m 57s
0.20 13h 31m 29s
0.10 21h 09m 08s
0.05 34h 20m 07s
proteins to form a new virion of radius 0.07 µm. These values are within the ranges reported
in literature for HIV virions [3, 5, 8, 9, 10, 42, 43]. We then convert 4,500 to moles by
Figure 2.9. Experimental Results. Gag was tagged with green-fluorescent
protein (GFP). A weak GFP signal begins to appear at about 35 h.p.i. on
Cos-7 cells, and at around 20 h.p.i. on HEK293T cells. Clearly visible puncti
(green dots), which may represent new HIV virions, appear at around 40 h.p.i.





. To convert the resulting value into µM, we divide by the
volume of a virion, calculated as the volume of a sphere of radius 0.07 µm. The resulting







Similarly, we estimate the value of the parameter g, the rate of production of new Gag
proteins in the cytoplasm, as follows. We assume that 1,500 Gag molecules are produced
inside the cytoplasm of a cell each second [40]. We also assume that the cytoplasm is an
annulus as depicted in Figure 2.4, with ra = 5µm and rb = 10µm. To convert to volume, we
assume that the cell is a cylinder, with height equal to 5µm [40]. We then convert this value





In addition, we set the value of the diffusion coefficient D = 0.04 µm2/s [16, 28]. The
value of the active transport coefficient s is varied within an acceptable range for transport
of cargo via motor proteins along microtubules [2, 32, 41, 44, 45].
Our simulation results agree principally with experimental results (see Figures 2.8 and
2.9, and Table 2.1). If HIV entry into the host cell takes roughly the same time as the HIV
egress, then the time post infection for the first virions to appear is about twice the time
of egress [16]. In experiments, Nermut et al. found that some cells produced VLPs after 36
h.p.i. and the majority reached VLP budding and release at about 40-44 h.p.i. [15].
2.4. Parallelization of Numerical Simulations
Motivation. In order to better understand distribution of parameter values, numerical
simulations are needed for a very large collection of parameter values s,D. This is a case of
Single Instruction Multiple Data (SIMD) [16].
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Overview. There are 4 major parameters: s,D,∆t, g. There are also many for-loops
in C++ code. We use MPI (message passing interface) for coarse-grain parallelism (runs
with different sets of parameters) and OpenMP for fine-grain parallelism (for-loops inside
each run).
Figure 2.10. Parallelization: Master-Worker. Source: [16].
MPI and OpenMP. For MPI parallelization, we use a master-worker approach. An
input file contains a collection of sets of parameter values. The master rank reads the file
and distributes the jobs among the worker ranks. Each worker sends its output, i.e., the
calculated virion time Tv, to the master rank, which then writes the output onto another file
for later analysis (see Figure 2.10).
We use OpenMP for parallelization within each worker rank. We first run gprof [47] for
parallelability analysis. gprof creates a code profile that helps us determine the parts of the
code (for-loops) that take longest to run. Then we use parallel sections to parallelize such
loops. Our parallel code was implemented and run on the Colorado State University (CSU)
Cray supercomputer (see Figure 2.11).
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Parallelization Speedup and Efficiency. Basic definitions:
• Speedup Si = T1/Ti
• Efficiency Ei = T1/(iTi)
• i = number of allocated cores
• Ti = time that it takes i cores to run a program
Parallel Simulations. Parameter values:
• s ∈ {1, 1.2, 1.4, ..., 3.0} µm/s
• D ∈ {0.02, 0.04, 0.06} µm2/s
• ∆t ∈ {0.125, 0.25, 0.5, 1.0} s
We fix g = 0.002114 µM/s. The simulations take longer to finish for smaller values of
s,D, and ∆t.
OpenMP parallelization had the most impact when fewer ranks were used. Execution
time was reduced by about 44% when 1 worker and 5 threads were used. We also observe
that there is no need to run the code with 133 ranks (132 workers). The parallel efficiency
was high with 5 threads and between 20 and 40 ranks (see Tables 2.2 and 2.3).
Figure 2.11. Cray Architecture. Source: [46].
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Table 2.2. Effects of the number of threads (OpenMP). Source: [16].
n (# of ranks) d (# of threads) Runtime (seconds) Speedup
2 1 929.67
2 5 521.33 1.78
133 1 21.00
133 2 17.33 1.23
Table 2.3. Effects of the number of ranks. Source: [16].
n (# of ranks) d (# of threads) Runtime (seconds) Efficiency
2 5 521.33
20 5 31.33 0.81
30 5 23.33 0.71
40 5 19.00 0.65
50 4 22.00 0.45
133 2 17.33 0.21
Table 2.4. Job Unevenness. Source: [16].
n (# of ranks) d (# of threads) Runtime (seconds) Efficiency
100 2 21.33 0.23
110 2 24.00 0.18
120 2 22.33 0.18
130 2 17.33 0.21
140 2 17.67 0.20
Executing the code with 110 and 120 workers took longer than with 100 ranks! (See
Table 2.4). Possible reasons are:
• There is additional overhead costs for additional allocated cores.
• There is unevenness of jobs: some cores finish their jobs quickly while others take
longer.
2.5. Stochastic Aspects of Gag Trafficking
Intracellular HIV Gag trafficking is dependent on microtubules and motor proteins, such
as kinesin. This protein exhibits predominantly anterograde (plus-ended) movement along
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microtubules. Kinesin moves either one or two steps at a time in a rather erratic manner.
The protein obtains energy by hydrolizing ATP in order to move along a microtubule. For
each ATP molecule hydrolized, conventional kinesin takes one 8nm step forward [44]. At
times, the protein stops and even detaches from the microtubule. The kinesin may re-attach
and continue its movement toward the cell periphery. Conventional kinesin may travel for
hundreds of ATPase cycles before dettaching from a microtubule [2, 44, 48].
Cargo attaches to kinesin based on protein binding affinity. The cargo may be membrane-
enclosed or free. In the absence of cargo, kinesin proteins tend to exhibit decreased binding to
microtubules and inhibited motility [49]. Comformational changes in kinesin might explain
this difference in binding and motility. Friedman and Vale [49] observe that cargo-free
kinesin is folded in such a way that the head and tail are in close proximity. Removal of
the kinesin tail promotes attachment to microtubules and increases microtubule-stimulated
ATPase activity. Thus, they conclude that the kinesin tail represses ATPase and the motility
of this protein along microtubules [49].
It has been observed that organelles move bidirectionally inside cells. Evidence suggests
that both types of motor proteins, kinesins and dyneins, attach to cargo simultaneously, and
directionality of movement is determined by a complex mechanism which ensures that when
one type of motor is active, the other one is inactive [29, 41]. In addition, the cell type, the
pH value, the type of cargo, and other factors can affect intracellular transport speed.
2.5.1. Stochastic Transport of Gag on Microtubules. The speed at which
cargoes move along microtubules is still an active area of research. According to Sodeik and
others [32], GFP-tagged HIV particles have a peak velocity of 1 µm/s as they travel through
the cytoplasm.
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Kinesins move along microtubules at a wide range of velocities [45]. Kinesin velocity can
be regarded as a random variable with a probability distribution. In experiments, Setz and
Surrey [45] estimated the average kinesin velocity to be about 0.56 µm/s (see figure 2.13).
In contrast, as observed by Gazzola and co-workers [41] in in vitro experiments, intracellular
Figure 2.12. Kinesin Walking and ATP Cycles. Source: [50].
Figure 2.13. Distribution of Kinesin Speeds. v = mean, w = standard
deviation. Source: [45].
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cargo, such as vesicles and intracellular viruses, have exhibited greater velocities than the
maximum speeds measured for motor proteins without load. Such maximum velocities listed
in [41] are:
• 3 µm/s for dynein
• 0.4 µm/s for kinesin-1
• 3 µm/s for kinesin-1
• 0.8 µm/s for kinesin-1
• 0.5 µm/s kinesin-2.
Similar motor protein velocities have been reported by Alberts, Coy, Seitz, and others [2,
44, 45].
2.5.2. Stochastic Aspect of Gag Transport at the Cell Level. For stochastic
analysis of Gag trafficking, one can focus on transport at the cell level instead of considering
transport at the molecular level. In other words, the emphasis can be on the overall variability
of transport velocities, Gag production rates, and nuclear and cell radii among cells, without
taking into consideration the specific mechanisms involved in the intracellular transport of
proteins.
We then can consider equation (1), where we have, over the space of all cells:
• Random input: speed (s), diffusion (D), production rate (g), nuclear radius (ra),
cell radius (rb)
• Random output: the time needed for puncta appearence (Tv)
• Parameter space: tensor grids vs sparse grids
There are several facts that should be taken into consideration for research on stochastic
aspects of HIV Gag trafficking, particularly relating to the speed at which particles are being
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transported and the amount of time it takes for Gag particles to assemble at the plasma
membrane. Here we list some of the most important data obtained from literature about
HIV Gag trafficking.
Some known facts regarding Gag transport and assembly time:
• The first Gag proteins appear in the cytoplasm at 28-30 h.p.i. [15].
• Budding starts 6-8 hours later, that is, 34-38 h.p.i. [15].
• Some cells produce VLPs after 36 h.p.i., while the majority of cells reach the VLP
budding and release state at about 40-44 h.p.i. [15].
• A subpopulation of Gag protein reaches the plasma membrane within 5-10 min
(after Gag synthesis begins) [7, 15].
Some known facts about the shape and size of VLPs:
• HIV Gag protein assembles into 100 to 120 nm diameter particles in mammalian
cells [51].
• Recombinant HIV Gag assembles in vitro into particles only 25-30 nm in diameter
if inositol phosphates not added [51].
• VLPs are about 100-150 nm in diameter, and contain several thousand Gag molecules
[42, 43].
• Gag proteins in immature HIV virions are highly extended rods: length about 20
nm, width of only 2 to 3 nm [43].
Some known facts about diffusion of particles in the cytoplasm are:
• The cell’s cytoskeleton (actin microfilaments, microtubules, and others) contribute 3000
µm2 of surface area in a typical mammalian tissue culture cell [28]
• Some typical diffusion coefficients for various cargoes in the cytoplasm are [28]:
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– 2.6 × 10−3 µm2/s for beads in SW3T3 fibroblasts
– 4.0 × 10−3 µm2/s for CV1 fibroblasts
– 2.5 × 10−2 µm2/s for endogenous vesicles
– 3.0 × 10−3 µm2/s for fluorescently stained stained chromatin granules
– 3.9 × 10−4 µm2/s to 7.4 × 10−3 µm2/s for secretory vesicles tagged with
GFP.
2.6. Remarks: Biological Implications
As noted above, our numerical results agree principally with experimental results. There-
fore, for appropriate combinations of parameter values it is possible to obtain virion assembly
times Tv that make sense according to the literature and experiments performed. This indi-
cates that the assumptions regarding diffusion and active transport are valid in the case of
HIV Gag trafficking:
• Diffusion alone is not enough to form a new HIV virion in a realistic time-frame.
• Gag particles move through the cytoplasm via diffusion and active transport.
• In addition, our simplifying assumptions, such as the annular model of the cyto-
plasm, linear transport in the radial direction and angular symmetry of transport
do not seem to have significant effect on the final results and might be feasible
assumptions for most cell types.
The importance of active transport could motivate some new clues for HIV. This means
that we could look for ways to suppress or disrupt active transport inside the cytoplasm, for
example, disrupting KIF4 or disrupting microtubules.
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2.7. Remarks on Further Work
Modeling Gag trafficking in the cytoplasm is a new research area in mathematical biology.
Presented in this dissertation is some preliminary work. Further work can be done in this
new area by developing further mathematical models that have assumptions better reflecting
the biological process and/or considering further complexity in the process.
Here we list some ideas for further work:
(1) Geometric domain other than the annulus could be used to better reflect the shape
of cells.
(2) Solving the stochastic transport equation to better characterize the randomness in










− s(ω)rP ) + g(ω),
r ∈ (ra(ω), rb(ω)), t ∈ (0, Tv), ω ∈ Ω
(D(ω)r ∂P
∂r
− s(ω)rP )|ra(ω) = (D(ω)r ∂P∂r − s(ω)rP )|rb(ω) = 0,
t ∈ (0, Tv), ω ∈ Ω
P (r, 0) = 0, r ∈ (ra(ω), rb(ω)), ω ∈ Ω.
Here, the set Ω is an abstract space whose elements are all possible outcomes ω. The
input parameters D, s, g, ra and rb are independent random variables. The solution
P is now a random quantity [52].
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(3) In addition, instead of employing characteristic finite element methods to numer-
ically solve the model, one could use Crank-Nicolson or other numerical methods
and evaluate the advantages and disadvantages of using these methods.
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CHAPTER 3
HIV Gag Trimerization at the Plasma Membrane
3.1. Gag Trimerization and Multimerization
Figure 3.1. Gag Hotspots. The sites of Gag multimerization and HIV as-
sembly comprise about 10% of the plasma membrane [40].
Gag proteins are transported inside the cell via diffusion and active transport towards
the plasma membrane (see Chapter 2). These proteins exist mostly as monomers and low
order multimers in the cytoplasm [6, 10, 12, 53]. In particular, Gag monomers and trimers
have significant relevance in the process of Gag multimerization and HIV assembly. Gag
trimers could be regarded as the basic building blocks or subunits for the immature HIV
virion capsid. HIV virus-like particles (VLPs) do not seem to form significantly inside the
host cell [9, 10]. Thus, trimers and higher order multimers form mainly at “Gag hotspots”
near or on the plasma membrane (see Figure 3.1). They attach to the membrane during the
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early stages of HIV assembly and budding. Gag proteins are recruited to the site of assembly
either directly from the cytosol [10] or via lipid rafts [6, 54]. As the local Gag concentration
at the plasma membrane increases, Gag multimerization is enhanced, which speeds up virion
assembly [6, 9, 30, 55, 56]. The stable binding of Gag proteins to the plasma membrane is
then crucial for successful virion formation, and it is achieved through a myristoyl switch
[6, 30, 55, 56].
Figure 3.2. HIV-1 Gag Domains and Myristoyl Switch. The main HIV-1
Gag domains are: matrix (MA), capsid (CA), nucleocapsid (NC), and p6.
Myristate is bound to the MA domain. It can exist in either sequestered
state (myr(s)), in Gag monomers, or exposed state (myr(e)), in Gag trimers.
Source: [6].
3.1.1. Myristoyl Switch. The main HIV-1 Gag precursor Pr55gag domains are: ma-
trix (MA), capsid (CA), nucleocapsid (NC), and p6 (see Section 1.2 and Figure 3.2). In
addition, myristate, a 14-carbon saturated fatty acid, covalently modifies the membrane-
binding (M) domain of MA at its N-terminal region. This process is called myristoylation.
A “myristoyl switch”, which promotes tight anchoring of Gag proteins to the plasma mem-
brane, consists of myristate plus a cluster of basic residues within the M domain that syner-
gizes with myristate [6, 56]. This myritoyl switch is, thus, essential in the assembly of new
HIV virions.
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3.1.2. Gag Status Near the Plasma Membrane. The myristate moiety in HIV-1
MA exists in two different states: monomeric sequestered (myr(s)) and trimeric exposed
(myr(e)) (see Figures 3.2 and 3.3). These two states of myristate in myr-MA exist in equi-
librium in the cytosol.
The exposure of myristate is coupled with trimerization [6, 54, 55, 56]. In particular,
binding of the MA domain to PI(4, 5)P2 helps localize Gag proteins on virion assembly
sites at the plasma membrane, which promotes Gag trimerization and triggers myristate
Figure 3.3. Molecular Model for myr(e)-MA Trimer. This model was pro-
posed by Tang et al. for myr(s)-MA monomer and myr(e)-MA trimer at equi-
librium, based on observations made in experiments that examined myristoy-
lated MA proteins. Binding of the myr(e)-MA trimer to the plasma mem-
brane may disrupt myr-myr interactions. The myristate is shown here in red.
Source: [56].
Figure 3.4. Trimerization and Membrane Binding of Gag. myr(e) Gag
trimers either bind or are bound to the plasma membrane, and they form
higher-order multimers as the new HIV virion assembles. Source: [6].
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exposure [30, 54] (see Figure 3.4). According to Jouvenet and coworkers, “Gag concentration
influences both the interaction between Gag molecules and the interaction between Gag and
the plasma membrane and is very probably a key determinant of assembly kinetics” [9]. Thus,
the increase in Gag concentration at the plasma membrane enhances multimerization and
myristate exposure, which in turn ensure tight anchoring of Gag to the plasma membrane.
In addition, myristate exposure is also enhanced by the CA and NC subdomains and the
binding of Gag to RNA [6, 56], and is modulated by pH [55]. Interestingly, the myristate
group remains sequestered in HIV-2 MA in the presence of PI(4, 5)P2 [54, 55]. Thus, the
assembly mechanisms for two closely related viruses may be quite different.
Based on the above findings from previous studies, we develop and analyze a mathemat-
ical model for HIV-1 Gag trimerization near the plasma membrane. The model considers
two main species: Gag monomers, corresponding to the myr(s) state, and Gag trimers, cor-
responding to the myr(e) state. We aim to better understand the relationships among the
variables and parameters involved in the dynamics of Gag trimerization and multimerization
at the site of virion assembly. We also analyze the model to show the existence of a stable
equilibrium between the monomeric myr(s) and trimeric myr(e) states of Gag protein.
3.2. Kinetic and Equilibrium Constants
Table 3.1 defines the general kinetic association and dissociation constants in a chemical
reaction. The chemical reaction can be respresented with the equation





In the context of our model of Gag trimerization, ka = k13 and kd = k31 correspond to the
rates of Gag trimerization and monomerization, respectively. The reaction towards the right
corresponds to trimerization, with k13 measured in 1mol
−2s−1, and the reaction towards the
left corresponds to monomerization, with k31 measured in 1s
−1.
Table 3.1. Relevant Kinetic Constants. Source: [57].
Association rate constant, ka Dissociation rate constant, kd
Definition A+B → AB AB → A+B
Description Reaction rate of AB formation: Dissociation rate of AB:
number of AB complexes formed number of AB complexes
per unit time at unit dissociating per unit time
concentration of A and B
Units 1mol−1s−1 1s−1
Table 3.2 defines the equilibrium association constant Ka. In the context of our mathe-
matical model, Ka is measured in 1mol
−2 and is defined as [40]
(21) Ka =
concentration of Gag trimers





Table 3.2. Relevant Equilibrium Constant. Source: [57].





Description Affinity to association:
high Ka means high affinity to associate
Units 1mol−1
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3.3. Mathematical Model for Two-species Gag Trimerization
3.3.1. Assumptions, Variables, and Parameters. Listed below are the main as-
sumptions for our model of HIV-1 Gag trimerization near the plasma membrane:
• Gag molecules arrive in monomeric form at the plasma membrane at a constant
rate.
• Trimerization is enhanced by increased Gag monomer concentration.
• Multimerization is enhanced by increased Gag trimer concentration.
• Molecules do not leave the area near the plasma membrane after they arrive.
• Once trimers attach and multimerize at the plasma membrane, they do not break
down into smaller molecules.
The variables and parameters utilized in our model are described below:
• P1 = concentration of Gag monomers
• P3 = concentration of Gag trimers
• g = arrival rate of new Gag monomers to the assembly site at the plasma membrane
• k13, k31 = Gag association (trimerization) and dissociation (monomerization) rates,
respectively
• γ = multimerization rate of trimers at the plasma membrane
3.3.2. Two-Species Model: Equations. We assume that Gag monomers arrive at
the site of Gag multimerization and virion assembly (“Gag hotspot”) at a constant rate.
Three Gag monomers can associate and give rise to a Gag trimer. A trimer can also dissociate
into three monomers. Gag trimers that multimerize and are tightly bound to the plasma
membrane are “harvested out” and do not break down into smaller molecules.
42









3 − k31P3 − γP3.
3.3.3. Matlab Implementation of the Two-Species Model. We describe here
our Matlab code, consisting of three files:
• setMonTriParams.m: This function sets values for the model parameters g, k13, k31,






, which can be used to set the
parameters values.
• MonTri.m: This function implements the model equations for the rates of change
of the concentrations of Gag monomers and trimers. MonTri first calls the function
setMonTriParams to get model parameters values, and then it uses these values to
implement the equations of the model. MonTri returns a vector with the differential
equations.
• simuMonTri.m: This script solves the differential equations numerically. It first sets
the initial and final times and initial values. Next, Matlab built-in solver ode45 is
called to solve the differential equation model implemented with the MonTri func-
tion. Then, the script produces a plot of the concentrations of Gag monomers and
trimers vs time.
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3.3.4. Two-Species Model: Equilibrium and Analysis. The equilibrium expres-
sions for the concentrations of myr(s) monomers and myr(e) trimers are:
(23)












Notice that the equilibrium concentration for myr(e)-Gag trimers does not depend on
the association and dissociation parameters k13 and k31, but it only depends on the Gag
monomer arrival and Gag trimer harvesting parameters. In particular, an increase in the
monomer arrival rate or a decrease in the trimer harvesting rate will increase the equilibrium
concentration of myr(e)-Gag trimers. Additionally, the equilibrium concentrations are posi-
tive, assuming that all parameter values and either P1(0) or P3(0) are positive. If P
∗
1 = 0 or
P ∗3 = 0, then g = 0, which implies that P
∗
1 = 0 = P
∗
3 .
The Jacobian matrix for system (22) is:
J =
 −9k13P 21 3k31
3k13P
2
1 −k31 − γ
 .
The eigenvalues of matrix J are:
λ± =
−(9k13P 21 + k31 + γ)±
√
(9k13P 21 + k31 + γ)
2 − 36k13γP 21
2
.
Let B = 9k13P
2








If B2 − 36k13γP 21 ≤ 0, then Re(λ±) < 0. Otherwise, λ− < 0 and
−36k13γP 21 < 0
⇒ B2 − 36k13γP 21 < B2
⇒
√
(B2 − 36k13γP 21 ) < B
⇒ −B +
√
(B2 − 36k13γP 21 ) < 0.
Hence, λ+ < 0.






























Figure 3.5. Gag Trimerization Model Simulations. Matlab simulations con-
firm our theoretical results. There is a stable equilibrium.
Therefore, the equilibrium is (locally) asymptotically stable, regardless of parameter val-
ues. Numerical simulations, utilizing Matlab’s ode45 subroutine and pplane8 [58], confirm
our result (see Figures 3.5 and 3.6). This result agrees with the literature, since it is known
that myr-Gag monomers and trimers approach an equilibrium state [6, 56]. Notice that the
two nullclines are the same when g = 0 = γ (see Figure 3.6). In that case, when there is no
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. For this trimerization process, the ranges of biolog-




Figure 3.6. Gag Trimerization Phase Portrait. The equilibrium point is lo-










Figure 3.7. myr-MA and myr-MA-CA Equilibria. Ka = (2.5±0.6)×108M−2
















is a good approximation for small values of γ, that is, when there is little
multimerization.
Tang and co-workers [56] estimated the equilibrium association constants for myr-MA and
myr-MA-CA at 20◦C (see Figure 3.7). In particular, the estimated equilibrium association
constant for myr-MA-CA is
Ka = (4.6± 1.1)× 109M−2,
which is about 20 times larger than the Ka value for myr-MA. We expect the corresponding
value of the equilibrium association constant Ka for myr-Gag to be larger than that for myr-
MA-CA, since the inclusion of the NC domain and association to RNA promote Gag-Gag
interactions and, thus, trimerization [6, 56].
From experimental data, it is known that at the site of virion assembly near the cell
membrane, the total Gag protein concentration at equilibrium
(25) c = P ∗1 + 3P
∗
3
is close to 10 µM, but could be as large as 1,000 µM [40], taking into account that the
threshold concentration of Gag for the formation of a new HIV virion with 1,500 Gag proteins
is about 1,409 µM. Based on the estimate from Tang et al. [56], we let Ka = 4.6 × 109 M−2
and use Mathematica to solve equations (24) and (25). We calculate that the concentration
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is between 3.60653 µM and 958.89 µM.
3.3.6. Condition For Equilibrium Shift to Gag Trimers. Here we determine
conditions on Ka and the model parameters that will ensure an equilibrium shift towards
the trimeric myr(e)-Gag state. When 50% of the Gag protein concentration at equilibrium
is monomeric, we have P ∗1 = 3P
∗
















If we use equations (23) and (24) to write condition (26) in terms of the model parameters,









Notice that for the example illustrated in Figure 3.5, with the concentration of trimers










According to Tang et al. [56], at equilibrium, the myr-MA concentration is 50% mono-
meric when the total concentration is 73 µM, and the myr-MA-CA concentration is 50%
monomeric when the total concentration is 17 µM1 at 20◦C. Now, suppose that the myr-
Gag equilibrium concentration is 50% monomeric when the total concentration is 10 µM
[40]. Then, the concentration of trimers P ∗3 ≈ 1.67 µM, and condition (26) implies that
Ka > 1.33× 1010M−2.
The lower bound for Ka found here is about 3 times larger than the estimate for myr-
MA-CA Ka by Tang et al. [56]. Comparing the Ka values given by Tang et al. for myr-CA
and myr-CA-MA [56] (see Figure 3.7), this estimate seems reasonable for myr-Gag.
3.4. Remarks: Biological Implications and Further Work
Our results show that there is a stable equilibrium between the myr-Gag monomer and
trimer species. Even though our model could potentially be enhanced, we can see that our
assumptions here are sufficient for capturing this important feature of the dynamics of Gag
trimerization at the plasma membrane, which has been observed in experiments on myr-
MA and myr-MA-CA. Thus, our assumptions of the dynamics of Gag trimerization and
multimerization at the plasma membrane, such as:
• Gag proteins arrive to the Gag hotspots as monomers at a constant rate;
• Gag multimers, which are formed from associations of trimers and attach tightly to
the plasma membrane, do not break down into smaller structures;
1This is a recent correction on Tang et al., PNAS (2004) [59].
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• the relationships between the variables and the monomerization, trimerization, and
multimerization parameters, as given by the model equations
seem to be reasonable.
Following, we comment on possible further work avenues on Gag trimerization modeling.
(1) Literature research and simulations may be performed to approximate the values of
the parameters for the rate of Gag monomer arrival g and/or Gag multimerization
γ. Only one of the two is necesssary, if the approximation for the ratio of these
parameters calculated here is used. Similarly, more research may allow one to ob-
tain approximations for the association and dissociation rates k13 and k31. These
parameter estimates can also help to determine a more accurate estimate for the
value of myr-Gag Ka, the equilibrium association constant.
(2) There are two timescales in the Gag trimerization model that we proposed and
analyzed here (see 22). In the first (fast) phase, near time t = 0, the concentrations
of monomers and trimers change very rapidly. In the second (slow) phase, the
concentrations of monomers and trimers approach equilibrium. Multiple timescale
analysis via perturbation methods may be performed on the trimerization model in
order to further investigate the behavior of the solution near t = 0.
(3) The mathematical model for Gag trimerization proposed here could be further im-
proved to better reflect the dynamics of Gag localization and HIV virion assembly
at the plasma membrane. For instance, instead of assuming that the arrival rate of
Gag monomers g is constant, one could consider g = g(c). That is, g might depend
on the total concentration c of Gag protein at the plasma membrane. As a Gag
hotspot becomes saturated, fewer Gag proteins may be transported to the area. A
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more accurate model might include a carrying capacity term for the arrival rate of
Gag monomers at the plasma membrane, thus, requiring g to depend on the value
of the concentration c.
Moreover, we should point out that one might consider a three-species model for Gag
trimerization. Such a model could include the concentrations of Gag monomers in myr(s)
state, Gag monomers in myr(e) state, and Gag trimers. On the other hand, according to
Tang and co-workers, myristate exposure and trimerization are coupled together [6, 56],






When enough Gag proteins have accumulated near the cell membrane, a new immature
HIV virion forms and buds off the host cell. In order for this new virion to become infective,
the virion needs to go through the maturation process. During maturation, an enzyme called
protease (PR) cleaves the Gag proteins inside the virion into their main domains: matrix
(MA), capsid (CA), and nucleo-capsid (NC). Approximately 1,200-5,000 MA molecules re-
main attached to the inner layer surrounding the virion [9, 10, 19], while roughly 1,200-1,500
CA molecules assemble to form the outer shell or capsid of the mature HIV virion’s core
[10, 18, 19] (see Table 4.1). The interior of the core contains two single strands of RNA asso-
ciated to thousands of NC proteins, as well as a few hundred copies of reverse transcriptase
and integrase enzymes [18, 19].
Figure 4.1. In Vitro and Reconstructed Images of HIV-1 CA Helical Tubes,
2D Hexagonal Crystals, and RSV Icosahedral Particles. Source: [60].
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We investigate mathematical models for the assembly of the CA proteins into the mature
virion’s capsid. In particular, the model, proposed by Zlonick’s group and studied also
by Hagan’s group (see, for instance, [22, 23]), consists of a system of ordinary differential
equations for the rates of change of the concentrations of CA subunit, intermediates, and
capsid. We apply this model to HIV by looking at two stages of the assembly process:
nucleation and elongation. Since a mature HIV capsid contains only 12 CA pentamers,
Figure 4.2. Disulfide Crosslinking Strategy Used to Obtain Soluble HIV-1
CA Hexamers for 3D Crystalization. Source: [60].
Figure 4.3. (a)(b) EM images of CA tubes for two different constructs; (c)(d)
profiles of cross-linked soluble hexamers, and expected positions of cross-linked
n-mers. The scale band represents 500nm. Source: [60].
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we assume that a nucleus is a hexagon of CA molecules (see Figures 1.6, 4.1, 4.2, 4.3,
and 4.4). Hence, nucleation for a single mature HIV capsid ends when the hexagon of
CA proteins is formed. Also, the forward rates for the reaction are smaller compared to
elongation. We perform numerical simulations of the model by using the Matlab subroutine
ode45 and plotting the concentration profiles for several intermediates, subunit, and capsid.
Our simulation results imply that the concentrations of all species approach an equilibrium.
We verify our results analytically. In particular, we show the existence of a unique and stable
equilibrium for the case N = 3.
4.2. Existing Work
Compared to mathematical models for Gag trafficking and multimerization, there is more
work on modeling HIV core assembly or broadly viral assembly [61, 62, 63, 64, 65, 66, 67,
68, 69, 70, 71, 72, 73, 74, 75, 76, 77].
Figure 4.4. (a) Spherical particles detected via EM, indicating the insertion
of pentamers. (b) Profile of cross-linked soluble pentamers with expected posi-
tions of cross-linked n-mers. Source: [60].
54
4.2.1. Ganser’s Group. Ganser and co-workers studied the structure of the core shell
for HIV virus-like particles (VLPs) via electron cryotomography [19]. They observed a
consistent tendency of the CA proteins to arrange in fullerene-like conical shapes. Cylindrical
and irregularly-shaped capsids were also observed (see Figure 4.5).
Figure 4.5. HIV-1 Virus-Like Particles (VLPs). Conical (red), cylindrical
(orange), and irreguarly-shaped (yellow) capsids were observed via electron
cryotomography of a cell culture. Source: [19].
4.2.2. Zlotnick’s Group. Reference [23] is one of Zlotnick’s earliest works on virus
capsid assembly. A system of differential equations for the rates of change of the concen-
trations of capsid subunits and intermediates is developed. These equations model capsid
assembly as a polymerization reaction. It is assumed that only one subunit (which could be
an oligomer) at a time associates to or dissociates from the growing structure. Association
of intermediates is not considered, as their concentration, in general, is low. For the most
part, in their simulations, only one forward rate constant kf is used, and the backward rate
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Table 4.1. HIV-1 VLPs Statistics. Source: [19].





























Asterisks (*) mark VLPs with multiple capsids.
constants kbn are calculated from the forward rate constant kf and an association constant




= kf ([polymern−1]− [polymern])[freesubunit]− kb[polymern].
In simulations, these equations were used to model the formation of a dodecahedron, where
each subunit is a pentagon. Numerical solutions of these equations were found using a fourth-
order Runge-Kutta method with STELLA. Two types of assembly models were considered:
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equilibrium assembly (EQ), where intermediates form and break apart in a way that there
are enough subunits available for the reaction to continue, and kinetically limited (KL), in
which the early reaction is slow in order to avoid kinetic trapping. Both models feature
sigmoidal growth of capsid, with an initial lag phase followed by rapid growth. The EQ
model is more susceptible to kinetic traps but does not require nucleation, as opposed to the
KL model. The EQ model is more appropriate for assembly processes where the association





where n is the number of subunits in the nucleus and kfn represents the net rate for nucleus
assembly.
In [78], rate equations are used to model assembly of dodecahedral (formed by twelve
pentamers) and icosahedral capsids (formed by 30 tetramers). Expressions are provided for
association constants for subunits and capsids as well as the equilibrium concentrations of
all species in terms of subunit. A typical equation from the system of rate equations A2 in




= fmsm[u][m− 1]− fm+1sm+1[u][m] + bm+1[m+ 1]− bm[m]
where sm is a degeneracy statistical factor, and fm and bm are forward and backward rates,
respectively, for the mth species. The backward rates are calculated from the forward rate
fm.
In [20], Katen and Zlotnick reiterate that virus capsid subunits interact through weak
contact energies, which leads to a globally stable, and yet dynamic, structure. Assembly
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is modeled, as before, as polymerization. First, there is a nucleation event. Then the
structure elongates “through a series of faster and/or more stable additions of subunit, until
an equilibrium between the polymer and the free subunits is reached” [20]. These steps
correspond to the lag phase, which ends when the nucleus is formed, the rapid growth
phase, and the saturation phase. On the other hand, in vitro, many capsids are assembled
simultaneously. The lag phase, in this case, ends with the formation of an “assembly line”
of intermediates and the first capsids begin to accumulate. During the elongation phase,
concurrent nucleation and elongation events happen, giving rise to more capsids. The system




= kelong,n−1[nuc+ n− 1][subunit]+
kdissoc,n+1[nuc+ n+ 1][subunit]
−kelong,n[nuc+ n][subunit] + (other terms).
Katen and Zlotnick also discuss conditions for kinetic trapping: 1) if the association ener-
gies (and, hence, forward rates) are too high, which causes the formation of intermediates too
rapidly, using up all of the subunits without forming complete capsids; 2) if nucleation hap-
pens too quickly, compared to elongation, which produces many metastable intermediates;
3) if there is “off-path assembly”, giving rise to metastable intermediates, as before.
4.2.3. Hagan’s Group. Hagan and Elrad consider in [22] a model of rate equations
developed by Zlotnick’s group (see eqn. (33) below). The model disregards malformed
capsids. It also assumes that only individual subunits associate and dissociate, and that
there is only one forward and one backward coefficient for each intermediate. Two types of
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simulations are considered: canonical (NVT) simulations, corresponding to in vitro empty-
capsid experiments; and steady-state ensemble simulations, where the concentration of free
subunits is independent of time, in order to measure the mean elongation times of growing
capsids. They also consider the nucleation-growth (NG) model and a classical nucleation
(CNT) model. As opposed to Zlotnick and co-workers, who use two forward rates, fnuc and
felong, for the NG model, Hagan and Elrad distinguish between nucleation and elongation
by using different intersubunit association free energies. Sigmoidal growth of capsids, as
previously described, was observed. Their results show good agreement with experimental
median assembly times. The main conclusions of this study are the following: 1) Lag times
correspond to the initial mean elongation times. 2) Mean elongation times vary inversely
with free subunit concentration. 3) If there is a critical nucleus size, it can be identified from
the concentration dependence of the median assembly time.
In [79], Kivenson and Hagan study capsid assembly around a polymer, such as RNA.
They model capsid as a cubic lattice and use Monte Carlo (MC) simulations. They observe
that, under optimal conditions, capsid assembly and incorporation of the polymer proceed
simultaneously and, in fact, the polymer helps stabilize the addition of subunits to the
growing capsids. The process is similar to capsid assembly described before. In general, there
is a nucleation stage, where a small partial capsid is formed attached to a polymer. Then,
the capsid grows by adding subunits to the partial capsid. A final phase follows, where the
capsid is completed. This last stage can be delayed until the polymer is completely encased
inside the capsid. In addition, there can be polymer-related kinetic traps, for instance, if
the polymer is too long and does not fit inside the capsid. Thus, successful capsid assembly
around a polymer is dependent on the polymer length. In particular, there is an optimal
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polymer length for maximum efficiency of capsid assembly. Another important observation
in Kivenson and Hagan’s work [79] is that the rates of nucleation and growth increase with
polymer length and with polymer-subunit interaction strength.
4.3. Dynamical System Model
Our approach is to model HIV core assembly using dynamical systems. Capsid assembly
is a complicated process and its mechanism has only begun to unravel. Several computational
and mathematical models for capsid assembly of viruses have been developed and analyzed
in recent years. The assembly model that we consider here, based on Zlotnick’s group’s
model [23], is a differential dynamical system, similar to a population model for interacting
species. Each species in this case represents a particular capsid intermediate or n-mer. Each
equation in the model describes the rate of change of the concentration of a particular n-mer
with respect to time. Several simplifications of the assembly process are used in building
this model.
Assumptions. Listed below are important assumptions for our models:
• Malformed capsids are not considered. All capsids have the same number of CA
subunits, and there are no lattices larger than a capsid.
• Only single subunits bind or unbind. Thus, partial capsids do not bind with each
other.
• There is only one association and dissociation coefficient for each intermediate size.
Both coefficients are, then, average rates of association and dissociation for a par-
ticular n-mer.
The above assumptions are based on those described in [22]. We adopt the model to
describe the dynamics of HIV capsid assembly by choosing parameter values appropriately.
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Variables and Parameters. Shown below is a list of the variables and parameters
in the dynamical system model and a brief description of each one:
• cn = concentration of the nth capsid intermediate (n-mer),
• fn = forward (association) rate,
• bn = backward (dissociation) rate,
• N = number of subunits that form the capsid.
In the case of the mature HIV capsid (core shell), N ≈ 1200 − 1500 [10, 18, 19]. This
implies that there are about 1200-1500 n-mers in the pathway between subunit and capsid.
Hence, we have between 1200 and 1500 species in the model. Each species has its own
rate equation, with its own forward and backward rates. Assuming that the capsid is the
most stable of the species (based on the work by Zlotnick, Hagan, and others as described
previously), we assume that the values of the forward coefficients fn tend to increase with
n. Similarly, we assume that the backward coefficients bn tend to decrease with n.
Intermediates: Association and Dissociation. The diagram below describes the



























Based on Equation (1) in [22]
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The path to a capsid starts with one CA subunit (a monomer). One CA protein at a
time is added to the growing capsid. The process is slow at first, until the first nucleus with
nnuc subunits, which we assume is a hexagon (nnuc = 6) in the case of HIV, forms. The
process then continues at a faster pace as more and more CA units are added to the growing
lattice until the capsid, composed of N CA proteins, is complete.
Full Equations. The assembly model that we consider is a dynamical system of first-
order, autonomous, nonlinear ordinary differential equations. We emphasize the fact that
the model is based on concentrations of subunits, intermediates, and capsids. Each equation
describes the rate of change of the concentration of a particular n-mer with respect to time.
The size of the system, i.e., the number of equations and variables, is determined by the










= fn−1c1cn−1 − fnc1cn − bncn + bn+1cn+1
n = 2, ..., N
fN = bN+1 = 0.
The equation fN = 0 represents the fact that the last n-mer, the capsid, does not associate
with any subunits. The largest n-mer possible is the capsid. For this reason, we also have
bN+1 = 0. Since there is no (N + 1)st n-mer, there is no dissociation rate for such n-mer.
Additionally, notice that the equations do not include a dissociation rate b1, as it is impossible
for subunits to dissociate.
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4.4. Matlab Implementation
Our Matlab code consists of three files, which we describe below:
• setAssemParams.m: This function sets the forward and backward parameter values
fn and bn. The parameters are chosen so that fn increases monotonically and bn
decreases monotonically with respect to n. The function receives the number of
subunits in a capsid (capsid size) and returns the vectors of fn and bn values.
• CapAssem.m: This function implements the model equations (concentrations of n-
mers). The function receives the number of subunits in a capsid and vector variables
for time and concentrations. It first calls setAssemParams to get the forward and
backward parameters values, and then it uses these values to implement the equa-
tions of the model. CapAssem returns a vector with the differential equations.
• simuCapAssem.m: This script solves the differential equations numerically. It first
sets the initial and final times, the capsid size, and initial values. Next, it calls ode45
to solve the differential equation model implemented with the CapAssem function.
Then, the script produces a plot of concentration profiles for some of the capsid
intermediates, as well as a plot of the subunit and the capsid concentrations versus
time.
4.5. In Silico
In this section, we describe our analysis of the model through numerical simulations per-
formed in Matlab.
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Parameters. As mentioned in the previous section, we chose arbitrary functions for
the forward and backward coeffiecients fn and bn. More specifically, fn increases and bn
decreases as n increases. This condition guarantees that the most stable of the species is
the capsid, while all other species, aside from the subunit, will tend to exist in very low
concentrations.
Initial Values. The initial concentrations of n-mers and capsids were set to 0. We
ran the code for two different concentrations (numbers) of subunits (CA): 1300 and 5000.























































Figure 4.6. Concentration Profiles for Intermediates.
In silico for c1(0) = 5000: See Figures 4.8 and 4.9.
Observations. The concentrations of subunit and intermediates decrease rapidly and
reach equilibrium at values close to zero. Capsid concentration increases in sigmoidal fashion
and reaches equilibrium at values that correspond closely to the total number of subunits
divided by 250 (see Figures 4.6, 4.7, 4.8, and 4.9).
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Figure 4.8. Concentration Profiles for Intermediates.
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4.6. Interpreting Results
In vivo and in vitro, we expect the formation of a single core, although multiple cores
may form [18, 19].
In silico, capsids are more stable than intermediates [16, 22].
The results agree with the literature, as it is known that the CA intermediates reach
an equilibrium [22]. It is interesting to notice that, under our assumptions for the forward
and backward parameters, the most important intermediates in the reaction seem to be
the subunits and the full capsid. At equilibrium, all other intermediates exist at very low
concentrations.































Figure 4.9. Concentration Profiles for Subunit and Capsid.
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4.7. Existence and Stability of Equilibrium
Dynamical System for N=3. For simplicity, we show that there exists a unique,










1 − f2c1c2 − b2c2 + b3c3
dc3
dt
= f2c1c2 − b3c3
The Jacobian determinant is
(35)
∣∣∣∣∣∣∣∣∣∣∣
−4f1c1 − f2c2 2b2 − f2c1 b3




This implies that our equations are not independent. We reduce the system by imposing
the mass conservation condition that the total concentration of subunit is constant (see A4
in [78]):










= −2f1c21 + 2b2c2 + b3







1 − f2c2c1 − b2c2 + b3
c1(0)− c1 − 2c2
3





− 4f1c1 − f2c2 2b2 − 2 b33 − f2c1
−b3
3
− 2f1c1 − f2c2 b2 − 2 b33 − f2c1
∣∣∣∣∣∣∣∣∣
= b2b3 + 4b3f1c1 + 3b2f2c2 + 6f2f1c
2
1 6= 0.
By the Implicit Function Theorem, we conclude that a unique equilibrium exists.
Equilibrium for a System of Size N. We can find an expression for the equilibrium
of the full system (33) by setting the left hand side of the equations to zero and solving for
all variables in terms of c∗1, the concentration of subunits at equilibrium [78].
The equilibrium concentration for an intermediate of size n is
(38) c∗n =
fn−1fn−2 · · · f2f1
bnbn−1 · · · b3b2
c∗1
n, n = 2, 3, ..., N.
Assuming that all of the forward and backward coefficients are positive, this equilibrium
is well defined. Moreover, equation (38) implies that, at equilibrium, all of the intermediates
have positive concentration values. If c∗m = 0 for some m, then c
∗
1 = 0, which implies
that c∗n = 0 for all n. We know that this is not possible, since we assume that the initial
concentration of subunits is nonzero.
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Stability Analysis for N=3. Let
B = b2 + b3 + 4f1c1 + f2(c1 + c2),
C = 2f1c1(2b3 + 3f2c1) + b2(b3 + 3f2c2),
D = B2 − 4C.







Assume that the equilibrium concentrations c1 and c2 are both nonnegative and that the
forward and backward parameters are all positive. With these assumptions, we have B > 0,
which implies that the equilibrium is asymptotically stable if D ≤ 0. Suppose that D > 0.
Then, the equilibrium is unstable if D > B2. But D = B2 − 4C < B2, since C > 0 by the
assumptions on the equilibrium and parameters. Therefore, the equilibrium is asymptoti-
cally stable.
Kinetic Trapping. Kinetic trapping can happen, for instance, if association rates for
nucleation are too large compared to the association rates for elongation [22]. In this case,
nuclei would form too quickly, depleting the subunit pool and halting the reaction before
capsids form.
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4.8. Cascaded Dynamical System Model
The capsid assembly process can be considered in two phases: nucleation and elongation.
While these two stages are not completely separate from one another, we can reasonably
assume that most of the significant nucleation occurs during the initial stage of the reaction,
that is, the lag phase. After the lag phase, most of the formed nuclei elongate (grow)
quickly to form larger intermediates and capsids. We can assume that this second phase,
characterized by rapid growth and accumulation, is dominated by elongation events.
We consider two separate systems of equations, one for each phase of capsid assembly.
Figure 4.10. HIV-CA N-mer Profiles During Nucleation. On most ex-
periments depicted here, CA subunits and 6-mers were the most prevalent.
Source: [60].
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Nucleation Model. The first system models nucleation. For HIV, we assume that a
nucleus is comprised of six CA subunits, a hexagon or hexamer. As evidenced in [60] (see
Figure 4.10), most intermediates during nucleation are present in the form of subunits and
hexamers. Our model for this phase of capsid assembly consists of six differential equations,
one for each of the first six species cn, where n = 1, 2, 3, 4, 5, 6. As before, c1 corresponds to
CA subunits, and c6 corresponds to hexamers (nuclei).
Figure 4.11. Assembly Paths for Nucleation Phase. CA hexamers can form
through various combinations of CA species: one monomer and one pentamer
(blue), three dimers (green), a dimer and a tetramer (yellow), two trimers
(red). Pentamers and smaller CA intermediates dissociate by the removal of
one CA monomer at a time.
Figure 4.11 describes the different pathways considered in the nucleation model. Two
subunits come together to form a dimer, a subunit and a dimer form a trimer, and so forth.
Also, a pentamer dissociates into a subunit and a tetramer, a tetramer dissociates into a
subunit and a trimer, and so on. The largest intermediate in this case is the nucleus or
hexamer. We consider four different pathways for the formation of hexamers. A hexamer
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forms from the association of: a subunit and a pentamer (blue), three dimers (green), a
dimer and a tetramer (yellow), and two trimers (red). We assume that hexamers are much
more stable structures than the dimers, trimers, tetramers, and pentamers, and therefore we
neglect their dissociation into smaller intermediates.











1 + b3c3 − 3f22c32 − f24c2c4 − f12c1c2 − b2c2
dc3
dt
= f12c1c2 + b4c4 − f13c1c3 − 2f33c23 − b3c3
dc4
dt
= f13c1c3 + b5c5 − f24c2c4 − f14c1c4 − b4c4
dc5
dt
= f14c1c4 − f15c1c5 − b5c5
dc6
dt
= f15c1c5 + f22c
3
2 + f24c2c4 + f33c
2
3
where fij is the coefficient for the association of an i-mer and a j-mer, and bi is the dissociation
coefficient for an i-mer.
We implemented these equations in Matlab, in a similar manner to model (33) (see
Figures 4.12 and 4.13). The concentration of hexamers increases and approaches the initial
concentration of CA subunits, while the concentrations of all other intermediates approach
zero.
Elongation Model. The elongation model equations are similar to equations (33).
In this case, each subunit is now a hexamer. N is the number of hexamers in a HIV-1 capsid.





















































































Figure 4.12. Concentration Profiles for CA Intermediates of Sizes 1 through
6: Nucleation.






































= fn−1h1hn−1 − fnh1hn − bnhn + bn+1hn+1
n = 2, ..., N
fN = bN+1 = 0.
Here, hn represents the concentration of an intermediate formed by n hexamers.
4.9. Remarks: Biological Implications and Further Work
Our analytical and numerical results show the existence of a stable equilibrium of CA
intermediates, which agrees with experimental results. Even though the dynamics of HIV
core assembly are not well understood, the assumptions of the models described here, such
as:
• modeling capsid assembly as a polymerization event
• the forward coefficient values increase and backward coefficient values decrease with
the size of CA intermediates
seem reasonable enough to capture this feature.
Possible avenues for further research on HIV core assembly are identified as follows:
(1) Further investigate the relationships between the forward and backward coefficients,
and the concentrations of intermediates via numerical simulations.
(2) Additional numerical simulations of the nucleation model for several combinations
of parameter values would produce various values for the concentration of hexamers.
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These values can be used as the initial concentrations of subunit for the elongation
model, which would then lead to different equilibrium concentrations of capsid and
intermediates. This would aid in understanding the effects of the various assembly
pathways considered in the nucleation process in terms of the cascaded dynamical
system model.
(3) The models may be modified by considering other assembly pathways in the nucle-
ation and elongation stages, to gain further insight into the significance of multiple




In this chapter we summarize the major contributions of this dissertation.
5.1. Gag Trafficking
We proposed a partial differential equation model for Gag trafficking that includes both
diffusion and active transport. We developed a characteristic finite element scheme to solve
the model numerically. In addition, we implemented the numerical scheme in parallel, uti-
lizing a master-worker approach that combines MPI and OpenMP. We ran simulations for
various parameter values and calculated the time Tv of virion assembly for each parameter
combination. In particular, we focused on the active transport parameter s. We varied this
parameter within an acceptable range of values, according to motor protein speeds reported
in literature. Our numerical simulations agree principally with biological experiments. The
times Tv obtained are within a reasonable range for Gag transport and virion assembly. Our
results indicate that diffusion is not enough for Gag trafficking. We deduce that at least one
active transport mechanism, e.g., via motor proteins along microtubules, is involved.
We also identified randomness in Gag trafficking. At the molecular level, motor proteins
such as the kinesin KIF4, which have been shown to play an important role in HIV Gag
trafficking, move erratically along microtubules. Cellular cargoes have also been observed to
be attached to more than one type of motor protein at a time. At the cell level, we observed
that kinesin speeds may vary widely within a cell. Also, diffusion and Gag production rates
vary from one type of cell to another. In order to study the randomness in Gag trafficking
at the cell level, one could study the relationships between the distributions of the diffusion,
active transport, and Gag production parameters and the time of virion assembly.
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5.2. Gag Trimerization
We developed and studied a two-species model for Gag trimerization near the plasma
membrane. The model is a system of two ordinary differential equations, corresponding to
the rates of change of concentrations of Gag monomers and trimers. Parameters considered in
the model are the rates of: Gag arrival, trimerization, monomerization, and multimerization.
We found the equilibrium solution, and showed that the equilibrium is stable regardless of
parameter values. We verified our results via numerical simulations. Our conclusions agree
with the literature, as an equilibrium between monomeric and trimeric particles in myr-MA
and myr-MA-CA experiments has been observed. In addition, we estimated the ratios of
model parameters based on information obtained from experiments and from literature. We
also determined a condition for equilibrium shift toward the trimeric Gag state and used
this condition to estimate a lower bound for the equilibrium association constant Ka for
myr-Gag.
Additionally, we identified avenues for further research on Gag trimerization modeling,
such as: utilizing the parameter ratios and the Ka estimates found here to find estimates
for all model parameters, refining the model by considering carrying capacity based on Gag
saturation at the Gag hotspot near the plasma membrane, and considering a three-species
model that includes Gag monomers in both myr(s) and myr(e) states.
5.3. HIV Core Assembly
We considered models for HIV core assembly. We first adapted a dynamical system
model for capsid assembly, proposed by Zlotnick and others, to HIV core assembly. The
system consists of ordinary differential equations that represent the rates of change of the
concentrations of CA intermediates. As part of our analysis, we showed the existence of a
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unique, stable equilibrium of the concentration of CA intermediates for the case when there
are three species. We also found an expression for the equilibrium concentrations in terms
of the equilibrium value of the CA subunit for model with N CA species. We examined the
theoretical analysis against numerical simulations, including the existence and stability of
the equilibrium and the sigmoidal growth of capsid concentration.
Next, we proposed a cascaded dynamical system model for HIV core assembly. This new
model consists of two subsystems, representing nucleation and elongation. The nucleation
model consists of six CA species, subunit through nucleus (hexamers), and considers various
assembly pathways that lead to the formation of the more stable species, i.e., the hexamers.
The model disregards dissociation of hexamers. Numerical simulations suggest that an equi-
librium exists, with all CA species approaching zero concentration, except for the hexamers.
The elongation model is similar to Zlotnick’s model, with each subunit representing now a
CA hexamer.
Suggestions for further work on HIV core assembly models include: investigating the
relationships between the forward (association) and backward (dissociation) coefficients, and
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